These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32445622)

  • 1. Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective.
    Biessels GJ; Nobili F; Teunissen CE; Simó R; Scheltens P
    Lancet Neurol; 2020 Aug; 19(8):699-710. PubMed ID: 32445622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline.
    Ehtewish H; Arredouani A; El-Agnaf O
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diabetic brain and cognition.
    Riederer P; Korczyn AD; Ali SS; Bajenaru O; Choi MS; Chopp M; Dermanovic-Dobrota V; Grünblatt E; Jellinger KA; Kamal MA; Kamal W; Leszek J; Sheldrick-Michel TM; Mushtaq G; Meglic B; Natovich R; Pirtosek Z; Rakusa M; Salkovic-Petrisic M; Schmidt R; Schmitt A; Sridhar GR; Vécsei L; Wojszel ZB; Yaman H; Zhang ZG; Cukierman-Yaffe T
    J Neural Transm (Vienna); 2017 Nov; 124(11):1431-1454. PubMed ID: 28766040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus.
    Groeneveld O; Reijmer Y; Heinen R; Kuijf H; Koekkoek P; Janssen J; Rutten G; Kappelle L; Biessels G;
    Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1253-1260. PubMed ID: 30355471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping mechanisms linking insulin resistance with cognition and neuroprogression in bipolar disorder.
    Cuperfain AB; Kennedy JL; Gonçalves VF
    Neurosci Biobehav Rev; 2020 Apr; 111():125-134. PubMed ID: 31978440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of diagnostic constructs for cognitive impairment in patients with type 2 diabetes mellitus.
    Groeneveld ON; van den Berg E; Rutten GEHM; Koekkoek PS; Kappelle LJ; Biessels GJ;
    Diabetes Res Clin Pract; 2018 Aug; 142():92-99. PubMed ID: 29802950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and pathological brain ageing.
    Cholerton B; Baker LD; Craft S
    Diabet Med; 2011 Dec; 28(12):1463-75. PubMed ID: 21974744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities.
    Srikanth V; Sinclair AJ; Hill-Briggs F; Moran C; Biessels GJ
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):535-545. PubMed ID: 32445740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids.
    Brook E; Mamo J; Wong R; Al-Salami H; Falasca M; Lam V; Takechi R
    Pharmacol Res; 2019 Mar; 141():291-297. PubMed ID: 30616019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DIABDEM project: A pilot study of prevalence of cognitive impairment in diabetes mellitus in 2 Hispanic countries].
    Bozanic A; Toro P; Formiga F
    Rev Esp Geriatr Gerontol; 2019; 54(6):339-345. PubMed ID: 31326101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive dysfunction in diabetes: how to implement emerging guidelines.
    Biessels GJ; Whitmer RA
    Diabetologia; 2020 Jan; 63(1):3-9. PubMed ID: 31420699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes.
    Ciudin A; Simó R
    Front Endocrinol (Lausanne); 2022; 13():1024794. PubMed ID: 36531450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report.
    Wallin A; Kapaki E; Boban M; Engelborghs S; Hermann DM; Huisa B; Jonsson M; Kramberger MG; Lossi L; Malojcic B; Mehrabian S; Merighi A; Mukaetova-Ladinska EB; Paraskevas GP; Popescu BO; Ravid R; Traykov L; Tsivgoulis G; Weinstein G; Korczyn A; Bjerke M; Rosenberg G
    BMC Neurol; 2017 May; 17(1):102. PubMed ID: 28535786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: a longitudinal study.
    Callisaya ML; Beare R; Moran C; Phan T; Wang W; Srikanth VK
    Diabetologia; 2019 Mar; 62(3):448-458. PubMed ID: 30547230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia.
    Li W; Huang E
    J Alzheimers Dis; 2016 May; 53(2):393-402. PubMed ID: 27163819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does left ventricular hypertrophy affect cognition and brain structural integrity in type 2 diabetes? Study design and rationale of the Diabetes and Dementia (D2) study.
    Patel SK; Restrepo C; Werden E; Churilov L; Ekinci EI; Srivastava PM; Ramchand J; Wai B; Chambers B; O'Callaghan CJ; Darby D; Hachinski V; Cumming T; Donnan G; Burrell LM; Brodtmann A
    BMC Endocr Disord; 2017 Apr; 17(1):24. PubMed ID: 28388897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Exercise on Type 2 Diabetes Mellitus-Related Cognitive Impairment and Dementia.
    Callisaya M; Nosaka K
    J Alzheimers Dis; 2017; 59(2):503-513. PubMed ID: 28598841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.